Nosocomial Infection

Acquired Antibiotic Resistance Threatens Sepsis Therapy

Published in TB and Outbreaks Week, March 7th, 2000

According to a study from England, the spread of resistance to antibiotics, such as beta-lactam agents, has seriously threatened the use of these antibiotics for nosocomial sepsis.

M.J. Wood and colleagues from the Birmingham Heartlands Hospital reported the need for alternate treatments because with the rise of Gram-positive bacterial pathogens, principally Staphylococcus aureus and enterococci, glycopeptide antibiotics were losing effectiveness.

Wood et al. stated, "there was, often, no therapeutic alternative to the glycopeptide antibiotics, vancomycin and teicoplanin, for empirical land often also the specific therapy of infections caused...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry